{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03719092",
            "orgStudyIdInfo": {
                "id": "OSU-18078"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2018-01838",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                }
            ],
            "organization": {
                "fullName": "Ohio State University Comprehensive Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant",
            "officialTitle": "Single, High Dose Vitamin A Replacement in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation",
            "therapeuticArea": [
                "Other"
            ],
            "study": "high-dose-vitamin-a-in-preventing-gastrointestinal-gvhd-in-participants-undergoing-donor-stem-cell-transplant"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-02-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-10-23",
            "studyFirstSubmitQcDate": "2018-10-23",
            "studyFirstPostDateStruct": {
                "date": "2018-10-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-05-10",
            "lastUpdatePostDateStruct": {
                "date": "2023-05-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Hannah Choe",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Ohio State University Comprehensive Cancer Center"
            },
            "leadSponsor": {
                "name": "Ohio State University Comprehensive Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This phase I trial studies the side effects and how well high dose vitamin A works in preventing gastrointestinal graft versus host disease (GVHD) in participants undergoing donor stem cell transplant. Vitamin A deficiency is associated with increased risk of gastrointestinal GVHD. Vitamin A regulates growth and differentiation of intestinal cells and may reduce risk of gastrointestinal GVHD.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. To assess the feasibility and safety of pre-transplant single, high dose vitamin A supplementation in adult allogeneic stem cell transplant recipients until day +28 after transplant.\n\nOUTLINE: This is a dose-escalation study.\n\nParticipants receive vitamin A compound orally (PO) or enterally once prior to stem cell transplant.\n\nAfter completion of study treatment, participants are followed up periodically."
        },
        "conditionsModule": {
            "conditions": [
                "Allogeneic Hematopoietic Stem Cell Transplantation Recipient"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Prevention (vitamin A compound)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants receive vitamin A compound PO or enterally once prior to stem cell transplant.\n\nonce over a given 24 hour period with or without food. We will re-dose at 2000 IU/kg (maximum 120,000 IU) if Week 2 Vitamin A levels remain within 10% of baseline Vitamin A.",
                    "interventionNames": [
                        "Dietary Supplement: Vitamin A Compound"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Vitamin A Compound",
                    "description": "Given PO or enterally",
                    "armGroupLabels": [
                        "Prevention (vitamin A compound)"
                    ],
                    "otherNames": [
                        "A 313",
                        "Anti-Infective Vitamin",
                        "Antixerophthalmic Vitamin",
                        "Aquasol A",
                        "Arovit",
                        "Avibon",
                        "Avitol",
                        "Axerol",
                        "Axerophthol",
                        "Axerophtholum",
                        "Biosterol",
                        "Biovit-A",
                        "Del-Vi-A",
                        "Ido A 50",
                        "Idrurto A",
                        "Lard Factor",
                        "Lard-Factor",
                        "Ledovit A",
                        "Micelle A",
                        "Mulsal A Megadosis",
                        "Oleovitamin A",
                        "Ophthalamin",
                        "Pedi-Vit-A",
                        "Retinol, all trans-",
                        "Rinocusi Vitaminico",
                        "Vitamin A",
                        "Vitamin A Alcohol",
                        "Vitamin A USP",
                        "Vitamin A1",
                        "Vitaminoftalmina",
                        "Vitaminum A",
                        "Vogan"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Vitamin A dose that achieves level in the upper quartile of normal range for sex in at least 2/3 cases without dose limiting toxicity",
                    "description": "Determining a Vitamin A dose administered within 14 days prior to transplant that maintains level in the upper quartile of normal range for sex at day 28 (+/- 7 days) after stem cell infusion as well as tolerable in adult allogeneic stem cell transplant recipients.\n\ndetermining a Vitamin A dose administered within 14 days prior to transplant that maintains level in the upper quartile of normal range for sex at day 28 (+/- 7 days) after stem cell infusion as well as tolerable in adult allogeneic stem cell transplant recipients.",
                    "timeFrame": "Up to day 28"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of gastrointestinal graft versus host disease",
                    "description": "Cumulative incidence of GI GVHD will be calculated and graphed.",
                    "timeFrame": "Up to day 180 after stem cell transplant"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients planned to undergo an allogeneic stem cell transplant (SCT) with an human leukocyte antigen (HLA)-matched (unrelated or related) or 1 allele mismatched (7/8) donor or haploidentical donor who received either myeloablative or nonmyeloablative conditioning for hematologic malignancies are eligible\n\nExclusion Criteria:\n\n* Vitamin A hypersensitivity or allergy\n* Baseline pre-transplant Vitamin A levels higher than the upper quartile of normal range for age\n* Abnormal liver enzymes outside of the institutional laboratory normal range within 30 days of screening\n* Abnormal total, indirect, or direct bilirubin outside of the institutional laboratory normal range within 30 days of screening\n* Enteral feeding intolerance\n* Medication intolerance\n* Pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ohio State University Comprehensive Cancer Center",
                    "role": "CONTACT",
                    "phone": "800-293-5066",
                    "email": "OSUCCCClinicaltrials@osumc.edu"
                },
                {
                    "name": "Rachel Dalton",
                    "role": "CONTACT",
                    "email": "Rachel.Dalton@osumc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Hannah Choe, MD",
                    "affiliation": "Ohio State University Comprehensive Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Ohio State University Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hannah Choe, MD",
                            "role": "CONTACT",
                            "phone": "614-293-5428",
                            "email": "Hannah.Choe@osumc.edu"
                        },
                        {
                            "name": "Hannah Choe, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "The Jamesline",
                    "url": "http://cancer.osu.edu"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014815",
                    "term": "Vitamins"
                },
                {
                    "id": "D000014801",
                    "term": "Vitamin A"
                },
                {
                    "id": "C000014794",
                    "term": "Retinol palmitate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018977",
                    "term": "Micronutrients"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000016588",
                    "term": "Anticarcinogenic Agents"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17544",
                    "name": "Vitamin A",
                    "asFound": "In accordance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M17558",
                    "name": "Vitamins",
                    "asFound": "Two",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M302395",
                    "name": "Retinol palmitate",
                    "asFound": "In accordance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21009",
                    "name": "Micronutrients",
                    "relevance": "LOW"
                },
                {
                    "id": "M16885",
                    "name": "Trace Elements",
                    "relevance": "LOW"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T468",
                    "name": "Vitamin A",
                    "asFound": "In accordance",
                    "relevance": "HIGH"
                },
                {
                    "id": "T462",
                    "name": "Retinol",
                    "asFound": "In accordance",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}